Ganolucidic acid A TN4109
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ganolucidic acid A exhibits cytotoxicity, has inhibitory activities against human HeLa cervical cancer cell lines. It shows significant anti-human immunodeficiency virus (anti-HIV)-1 protease activity with IC50 values of 20-90 microM.
CAS nr:
98665-21-5
Purity:
98%
Molecular Weight:
500,67
SMILES:
C[C@H](CC(=O)CC(C)C(O)=O)C1C[C@H](O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1CC3
Formula:
C30H44O6
Pathway:
Proteases/Proteasome,Microbiology/Virology
Target:
HIV Protease,HIV Protease
